{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T04:33:28Z","timestamp":1787114008556,"version":"build-2736575974"},"reference-count":20,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.clinthera.2026.04.014","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:20:56Z","timestamp":1778880056000},"page":"898-901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Integrity in Medical Cannabis: The Pharmacist Perspective"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-5132-2724","authenticated-orcid":false,"given":"Sang","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2026.04.014_bib0001","unstructured":"New York State Department of Health. Medical use of marijuana under the Compassionate Care Act: two-year report. https:\/\/cannabis.ny.gov\/system\/files\/documents\/2023\/03\/medical-use-of-marijuana-two-year-report-9-27-18.pdf. Accessed August 1, 2025."},{"key":"10.1016\/j.clinthera.2026.04.014_bib0002","unstructured":"New York State Office of Cannabis Management. Patients. https:\/\/cannabis.ny.gov\/patients. Accessed August 1, 2025."},{"key":"10.1016\/j.clinthera.2026.04.014_bib0003","unstructured":"Drug Topics. The role of the pharmacist in cannabis legalization. https:\/\/www.drugtopics.com\/view\/the-role-of-the-pharmacist-in-cannabis-legalization. Accessed August 1, 2025."},{"key":"10.1016\/j.clinthera.2026.04.014_bib0004","unstructured":"Association of Cannabinoid Specialists. Opportunities for pharmacists in the medical cannabis industry. https:\/\/www.cannaspecialists.org\/pharmacists_in_the_cannabis_industry. Accessed August 1, 2025."},{"key":"10.1016\/j.clinthera.2026.04.014_bib0005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/1715163518813314","article-title":"Pharmacists\u2019 role in cannabis dispensing and counselling","volume":"152","author":"Dattani","year":"2018","journal-title":"Can Pharm J (Ott)"},{"key":"10.1016\/j.clinthera.2026.04.014_bib0006","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12875-023-02095-5","article-title":"Cannabis dispensary staff approaches to counseling on potential contraindications to cannabis use: insights from a national self-report survey","volume":"24","author":"Slawek","year":"2023","journal-title":"BMC Prim Care"},{"key":"10.1016\/j.clinthera.2026.04.014_bib0007","doi-asserted-by":"crossref","DOI":"10.1177\/2150132719831871","article-title":"Medical marijuana knowledge and attitudes: a survey of the California Pharmacists Association","volume":"10","author":"Szyliowicz","year":"2019","journal-title":"J Prim Care Community Health"},{"key":"10.1016\/j.clinthera.2026.04.014_bib0008","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/can.2019.0013","article-title":"Survey of pharmacists\u2019 knowledge of Connecticut\u2019s medical cannabis program","volume":"6","author":"Reece","year":"2021","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.clinthera.2026.04.014_bib0009","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.cptl.2024.03.007","article-title":"Assessment of education in a community hospital on healthcare providers\u2019 knowledge of and attitudes toward medical marijuana","volume":"16","author":"Meyers","year":"2024","journal-title":"Curr Pharm Teach Learn"},{"key":"10.1016\/j.clinthera.2026.04.014_bib0010","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/jgs.18180","article-title":"Trends in emergency department visits associated with cannabis use among older adults in California, 2005\u20132019","volume":"71","author":"Han","year":"2023","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.clinthera.2026.04.014_bib0011","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/ijpp.12462","article-title":"Community pharmacist-led interventions and their impact on patients\u2019 medication adherence and other health outcomes: a systematic review","volume":"26","author":"Milosavljevic","year":"2018","journal-title":"Int J Pharm Pract"},{"key":"10.1016\/j.clinthera.2026.04.014_bib0012","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1177\/17151635231164997","article-title":"An examination of cannabis-related information typically asked by consumers at retail cannabis locations: a Canadian survey of budtenders and managers","volume":"156","author":"Cameron","year":"2023","journal-title":"Can Pharm J (Ott)"},{"key":"10.1016\/j.clinthera.2026.04.014_bib0013","unstructured":"New York State Office of Cannabis Management. NYS medical cannabis program patient & provider survey report. https:\/\/cannabis.ny.gov\/system\/files\/documents\/2024\/06\/2023-medical-cannabis-survey-report.pdf. Accessed August 1, 2025."},{"key":"10.1016\/j.clinthera.2026.04.014_bib0014","unstructured":"Pharmacy Times. Pharmacists in medical cannabis care models: a review. https:\/\/www.pharmacytimes.com\/view\/pharmacists-in-medical-cannabis-care-models-a-review-as-medical-cannabis. Accessed August 1, 2025."},{"key":"10.1016\/j.clinthera.2026.04.014_bib0015","unstructured":"Canadian Pharmacists Association. A pharmacy dispensing model and the status quo. Conference Board of Canada. https:\/\/www.pharmacists.ca. Accessed August 1, 2025."},{"key":"10.1016\/j.clinthera.2026.04.014_bib0016","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/02791072.2011.587700","article-title":"Who are medical marijuana patients? Population characteristics from nine California assessment clinics","volume":"43","author":"Reinarman","year":"2011","journal-title":"J Psychoactive Drugs"},{"issue":"4","key":"10.1016\/j.clinthera.2026.04.014_bib0017","first-page":"96","article-title":"Medical cannabis use and healthcare utilization among patients with chronic pain: a causal inference analysis using TMLE","volume":"13","author":"Doucette","year":"2025","journal-title":"Pharmacy (Basel)"},{"key":"10.1016\/j.clinthera.2026.04.014_bib0018","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.japh.2021.11.023","article-title":"Description of collaborative, fee-for-service, office-based, pharmacist-directed medical cannabis therapy management service for patients with chronic pain","volume":"62","author":"Bellnier","year":"2022","journal-title":"J Am Pharm Assoc (2003)"},{"key":"10.1016\/j.clinthera.2026.04.014_bib0019","unstructured":"University of Maryland School of Pharmacy. Graduate studies in medical cannabis. https:\/\/www.pharmacy.umaryland.edu\/academics\/graduate-studies-in-medical-cannabis\/. Accessed August 1, 2025."},{"key":"10.1016\/j.clinthera.2026.04.014_bib0020","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.japh.2023.05.014","article-title":"Changes in Arkansans\u2019 attitudes toward pharmacist involvement and regulation of medical cannabis following its availability in Arkansas","volume":"63","author":"Hernandez","year":"2023","journal-title":"J Am Pharm Assoc (2003)"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929182600130X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014929182600130X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:34:07Z","timestamp":1787070847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014929182600130X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S014929182600130X"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.04.014","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Integrity in Medical Cannabis: The Pharmacist Perspective","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}